CHICAGO, March 22, 2017 -- Amlan International, known to improve livestock productivity around the world, introduces its new website with interactive elements designed to further educate the industry on the significance of intestinal health and enteric diseases to their bottom-line. This newly redesigned website presents simple access to essential information that offers species specific research and detailed product information. Advanced medical animations allow viewers to engage in the company’s content and offers a distribution map linking to Amlan sales representatives’ contact info.
The new website has improved functionality and is in-line with Amlan’s new strategic vision. Product information is comprehensive and current.
“We are excited to launch our new website and the rich content it will provide our customers, consumers, and media,” said Dr. Ron Cravens, President of Amlan International, a Nevada Corporation. “This website will focus on our mission of researching and developing products that lead to better intestinal health.”
Amlan International’s new website will be updated regularly with new product data, news releases, and events. Visitors are encouraged to visit Amlan International at Amlan.com and sign up for their newsletter and to receive new product content.
About Amlan International
Oil-Dri Corporation of America (NYSE:ODC), a Delaware corporation and doing business as “Amlan International”, helps producers increase animal productivity by developing products that enhance intestinal health and function. Since its inception in 2007, Amlan has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted in its laboratory campus in Vernon Hills, IL. In 2013, the company’s global reach expanded with the establishment of its China subsidiary in Shenzhen. Further information on Amlan International is available at Amlan.com.
Amlan–Productivity for Life.
Media Contact Mike McPherson 312.706.3379 [email protected] www.amlan.com


Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Instagram Outage Disrupts Thousands of U.S. Users
Washington Post Publisher Will Lewis Steps Down After Layoffs
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 



